Expression of CD133 correlates with differentiation of human colon cancer cells

Cancer Biology and Therapy

Volumn 9, Issue 3, 2010, Pages 216-223

  Feng, Hai Liang ^a   Liu, Yu Qin ^a   Yang, Li Juan ^a   Bian, Xiao Cui ^a   Yang, Zhen Li ^a   Gu, Bei ^a   Zhang, Hong ^a   Wang, Chun Jing ^a   Su, Xiao Ling ^a   Zhao, Xiao Mei ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Cancer stem cells; Carcinoma cell lines; CD133; Colon cancer; Differentiation; siRNA; Tumor initiating cells

Indexed keywords

CD133 ANTIGEN; CELL MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL MOTILITY; CELL SUBPOPULATION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONIC NEOPLASMS; COLONY-FORMING UNITS ASSAY; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED BALB C; PEPTIDES; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953533181     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.3.10664     Document Type: Article

References (26)

1. Yin AH, Miraglia S, Zanjani ED, meida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90:5002-12.
2. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008; 86:1025-32.
3. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization and molecular cloning. Blood 1997; 90:5013-21.
4. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008; 214:3-9.
5. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-8.
6. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445:111-5. (Pubitemid 46067311)
7. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106-10. (Pubitemid 46067310)
8. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65:10946-51. (Pubitemid 41713363)
9. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007; 120:1444-50.
10. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007; 6:92-7. (Pubitemid 46243168)
11. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000; 2:582-92.
12. + cells in vitro. Differentiation 2007; 75:100-11.
13. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008; 27:1749-58.
14. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006; 66:7445-52. (Pubitemid 44289197)
15. Clement V, Sanchez P, de TN, Radovanovic I, Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal and tumorigenicity. Curr Biol 2007; 17:165-72. (Pubitemid 46107823)
16. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444:761-5. (Pubitemid 44949605)
17. Chung YS, Song IS, Erickson RH, Sleisenger MH, Kim YS. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 1985; 45:2976-82.
18. Al-Hajj M, Wicha MS, ito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-8.
19. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 2008; 15:638-48. (Pubitemid 351643025)
20. Du L, Wang H, He L, Zhang J, Ni B, Wang X, et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008; 14:6751-60.
21. + and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118:2111-20.
22. Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, Watt SM, et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000; 275:5512-20.
23. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005; 319:15-26.
24. Taieb N, Maresca M, Guo XJ, Garmy N, Fantini J, Yahi N. The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett 2009; 278:164-73.
25. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, et al. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 2009; 219:427-34.
26. Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008; 26:3008-17.